In 2019 and 2020, a formulation of Semaglutide (brand name Rybelsus) was approved as a daily oral medication for treating diabetes, when used along with diet and exercise
Researchers think that this involves the vagus nerve .[ref] Vagus nerve interaction: A 2026 study showed that the GLP-1 receptor is expressed in the nodose neurons, which are the sensory cells that transmit information from the internal organs to the brainstem.[ref] GLP-1 Medications: Semaglutide, Tirzepatide, and Retatrutide Given GLP-1s powerful effects on appetite and glucose regulation, researchers developed synthetic medications that mimic its action
The efficacy of subcutaneous semaglutide was established in the phase III SUSTAIN program (SUSTAIN 15 and 7), in which significant reductions in mean glycated hemoglobin (HbA 1c ) and body weight were demonstrated against placebo and a variety of active comparators in multiple patient groups with T2D [26,27,28,29,30,31,32,33]
Semaglutide Injection Semaglutide injection- Picture courtesy: myethosspa Extremely Potent and Effective The semaglutide injection for the management of T2D or weight loss gives similar effects as tablets, but you will experience more pronounced effects than semaglutide tablet
